These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2068154)

  • 1. Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
    Cheung NK; Burch L; Kushner BH; Munn DH
    Prog Clin Biol Res; 1991; 366():395-400. PubMed ID: 2068154
    [No Abstract]   [Full Text] [Related]  

  • 2. 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.
    Cheung NK; Kushner BH; Yeh SJ; Larson SM
    Prog Clin Biol Res; 1994; 385():319-28. PubMed ID: 7972227
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK; Guo HF; Heller G; Cheung IY
    Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
    Cheung NK; Saarinen U; Neely J; Miraldi F; Strandjord S; Warkentin P; Coccia P
    Prog Clin Biol Res; 1985; 175():501-5. PubMed ID: 3991743
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
    Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
    Clin Cancer Res; 1998 Sep; 4(9):2135-9. PubMed ID: 9748131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
    Cheung NK; Lazarus H; Miraldi FD; Abramowsky CR; Kallick S; Saarinen UM; Spitzer T; Strandjord SE; Coccia PF; Berger NA
    J Clin Oncol; 1987 Sep; 5(9):1430-40. PubMed ID: 3625258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.
    Seeger RC; Reynolds CP; Vo DD; Ugelstad J; Wells J
    Prog Clin Biol Res; 1985; 175():443-58. PubMed ID: 3887429
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
    Cheung NK; Cheung IY; Canete A; Yeh SJ; Kushner B; Bonilla MA; Heller G; Larson SM
    Cancer Res; 1994 Apr; 54(8):2228-33. PubMed ID: 8174131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
    Maritaz O; Combaret V; Favrot MC
    Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of neuroblastoma cells from bone marrow by a direct monoclonal antibody rosetting technique.
    Berthold F; Schumacher R; Schneider A; Bosslet K; Reiter C
    Bone Marrow Transplant; 1989 May; 4(3):273-8. PubMed ID: 2659112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very long delay to engraftment after ABMT in neuroblastoma patients and effect of CD8 monoclonal antibody in vivo therapy.
    Favrot MC; Philip T; Combaret V; Biron P; Morisset J; Bernard A
    Prog Clin Biol Res; 1988; 271():225-36. PubMed ID: 3043450
    [No Abstract]   [Full Text] [Related]  

  • 15. Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.
    Cheung IY; Lo Piccolo MS; Kushner BH; Cheung NK
    J Clin Oncol; 2003 Oct; 21(20):3853-8. PubMed ID: 14551304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.
    Cheung NK; Sowers R; Vickers AJ; Cheung IY; Kushner BH; Gorlick R
    J Clin Oncol; 2006 Jun; 24(18):2885-90. PubMed ID: 16682723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
    Cheung IY; Lo Piccolo MS; Collins N; Kushner BH; Cheung NK
    Cancer; 2002 Jun; 94(11):3042-8. PubMed ID: 12115395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads.
    Reynolds CP; Seeger RC; Vo DD; Black AT; Wells J; Ugelstad J
    Cancer Res; 1986 Nov; 46(11):5882-6. PubMed ID: 3756928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
    Cheung NK; Kushner BH; Yeh SD; Larson SM
    Int J Oncol; 1998 Jun; 12(6):1299-306. PubMed ID: 9592190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-3F8: clinical validation of imaging studies and therapeutic applications.
    Cheung NK; Yeh SD; Gulati S; LaQuaglia M; Burch L; Kushner BH; Larson S
    Prog Clin Biol Res; 1991; 366():409-15. PubMed ID: 2068155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.